![](https://www.biopharmadive.com/imgproxy/HJZjth9NJwPpQapW88niTiC7L0uuyZN2H5gT_elJN1w/g:ce/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTE1NDk0NjUwOV9ZSUk0bTdsLmpwZw==.webp)
Exsilio debuts with $82M, pitching a ‘leap’ forward for genetic medicine
Exsilio Therapeutics, a biotechnology startup led by a former Moderna executive, emerged from stealth Tuesday with an approach it claims can solve some of the shortcomings of genetic medicines. The Boston-based company is debuting with $82 million from a …